Loading...

HCV (HEPATITIS C VIRUS) GENOFIBRO PROFILE

image not found

NABL Cap Accredited 
The HCV (Hepatitis C Virus) Genofibro Profile at Metropolis Healthcare is a comprehensive evaluation that assesses both the genotype of the virus and the level of liver fibrosis. This combined approach provides crucial insights for personalized treatment planning and monitoring disease progression. Using advanced molecular testing and fibrosis markers, Metropolis Healthcare ensures accurate, clinically meaningful results. This profile is essential for patients diagnosed with or suspected of having chronic Hepatitis C infection.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 24,960.00

Sample Type: Serum

Fasting Not Required


Frequently Asked Questions (FAQ's):

What does the HCV Genofibro Profile include at Metropolis Healthcare?
It includes HCV genotyping along with fibrosis assessment markers to evaluate liver damage and guide tailored treatment decisions.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced molecular diagnostic platforms and validated fibrosis assays to deliver precise and reliable results.

Who should consider taking the HCV Genofibro Profile?
Individuals diagnosed with Hepatitis C or those suspected to have chronic liver disease may benefit from this detailed assessment.

Is fasting required before this test at Metropolis Healthcare?
Fasting is generally not required, though Metropolis Healthcare may provide specific pre-test instructions if needed.

How soon can I expect the results from Metropolis Healthcare?
Results are usually available within the standard processing time for molecular and fibrosis tests, with secure digital access.

Does this test help in treatment planning?
Yes, knowing the HCV genotype and fibrosis stage helps clinicians choose the most appropriate antiviral therapy and monitor response.

Can this profile detect early liver damage at Metropolis Healthcare?
Yes, fibrosis markers included in the profile help identify both early and advanced liver changes.

Is this test useful for monitoring long-term liver health?
Absolutely—repeat testing can help track liver improvement or progression during and after treatment.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab